StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.15−0.04 (-1.83%)

Close on Nov 16, 2026Market cap $93.09MP/E –Yield –

NRX Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for NRX Pharmaceuticals

NRX Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More NRX Pharmaceuticals figures

See a number that looks wrong?